Pegadricase

DB15129InvestigationalProtein Based Therapies

Pegadricase is under investigation in clinical trial NCT01021241 (Safety and Efficacy Study of Intravenous Uricase-PEG 20).

Mechanism
Curator reviewed
Also known as
Pegsitacase · Pegsiticase · PEGylated recombinant candida urate oxidase · SEL 037 · SEL-037

Resolves to

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Pegadricase, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account